Skip to Content


  1. Macfarlane, et al. (2008) “Bacterial metabolism and health‐related effects of galacto‐oligosaccharides and other prebiotics.” Journal of applied microbiology 104(2) 305-344.
  2. Lohner, Szimonetta, et al. (2014)”Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis.” Nutrition reviews 72(8) 523-531.
  3. Drakoularakou, et al. (2010) “A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galactooligosaccharide mixture in reducing travellers’ diarrhoea.” European Journal of Clinical Nutrition 64(2) 146-152.
  4. Whisner, et al. (2013) “Galacto-oligosaccharides increase calcium absorption and gut Bifidobacteria in young girls: a double-blind cross-over trial.” Brit Journal of Nutrition 110, 1292- 1303.
  5. van den Heuvel, et al. (2000) “Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women.” The Journal of Nutrition, 130(12), 2938-2942.
  6. Sanwalka, N. J., et al. (2012) “Galacto-fructo-oligosaccharide fortification of fermented non-dairy snack enhances calcium absorption in healthy adolescent girls.” International journal of food sciences and nutrition, 63(3), 343-352.
  7. Teuri, et al. (1998) “Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt.” Journal of Nutritional Science and Vitaminology 44(3) 465-471.
  8. Teuri, et al. (1999) “Galactooligosaccharides relieve constipation in elderly people.” Annals of Nutrition and Metabolism 42(6) 319-327.
  9. Sairanen, et al. (2007) “Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects.” European Journal of Clinical Nutrition 61(12) 1423-1428.
  10. Reid. (2016) "Probiotics: definition, scope and mechanisms of action" Best Practice and Research Clinical Gastroenterology 30(1) 17-25.
  11. Moro, et al. (2005) “Dietary prebiotic oligosaccharides are detectable in the faeces of formula‐fed infants.” Acta Paediatrica 94.s449: 27-30
  12. Bouhnik, et al. (1997) “Administration of transgalacto-oligosaccharides increases fecal Bifidobacteria and modifies colonic fermentation metabolism in healthy humans.” The Journal of nutrition 127(3) 444-448.
  13. Gibson, et al. (2017) "Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics" Nature Reviews Gastroenterology and Hepatology 14(8) 491-502.
  14. Bode, L. (2012) “Human milk oligosaccharides: Every baby needs a sugar mama.” Glycobiology 22(9) 1147-1162.
  15. Ito, et al. (1990) “Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation.” Microbial Ecology in Health and Disease 3(6) 285-292.
  16. Stiverson, et al. (2014) "Prebiotic Oligosaccharides: Comparative Evaluation Using In Vitro Cultures of Infants’ Fecal Microbiomes." Applied and Environmental Microbiology 80(23) 7388-7397.
  17. Varki, A., et al. (2015) “Symbol nomenclature for graphical representations of glycans.” Glycobiology 25(12), 1323-1324.
  18. Watson, D., et al. (2013) “Selective carbohydrate utilization by lactobacilli and bifidobacteria” Journal of applied microbiology, 114(4), 1132-1146.
  19. den Besten, et al. (2013) “The role of short chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism.” Journal of lipid research 54(9) 2325-2340.
  20. Suzuki, et al. (2008)” Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability.” British journal of nutrition 100 (2) 297-305.
  21. Gamet, et al. (1992) “Effects of shortchain fatty acids on growth and differentiation of the human colon‐cancer cell line HT29.” International Journal of Cancer 52(2): 286-289.
  22. Cherrington, et al. (1991) “Short chain organic acids at pH 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation.” Journal of Applied Bacteriology 70(2) 161-165.
  23. Tan, et al. (2014) “The role of short-chain fatty acids in health and disease.” Adv Immunol 121(9).
  24. Bhatia, S., et al. (2015) “Galacto‐oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells.” Molecular nutrition & food research, 59(3), 566-573.
  25. Pratt, et al. (1996) “Short-chain fatty acid-supplemented total parenteral nutrition improves nonspecific immunity after intestinal resection in rats.” Journal of Parenteral and Enteral Nutrition 20(4) 264-271.
  26. Bindels, et al. (2015) “Towards a more comprehensive concept for prebiotics.” Nature Reviews Gastroenterology & Hepatology 12(5) 303-310.
  27. De Vuyst, Luc, & Leroy, Frederic. (2011). “Cross feeding between bifidobacteria and butyrate producing colon bacteria explains bifidobacterial competitiveness, butyrate production, and gas production”. International journal of food microbiology. 149 (1). 73-80
  28. Louis, P., & Flint, H. J. (2009) “Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine.” FEMS microbiology letters, 294(1), 1-8.
  29. Yassour, M., et al. (2016) “Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability.” Science translational medicine, 8(343), 343ra81-343ra81
  30. Akbari, et al. (2017) "Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size" European Journal of Nutrition 56(5) 1919-1930
  31. Ortega‐González, M., et al. (2014) “Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4‐NFκB.” Molecular nutrition & food research 58(2), 384-393.
  32. Vandenplas, Y., Zakharova, I. and Dmitrieva, Y. (2015) "Oligosaccharides in infant formula: more evidence to validate the role of prebiotics" British Journal of Nutrition 113(9) 1339-1344.
  33. de Kivit, et al. (2017) “Dietary, nondigestible oligosaccharides and Bifidobacterium breve M-16V suppress allergic inflammation in intestine via targeting dendritic cell maturation.” Journal of Leukocyte Biology, jlb-3A0516.
  34. Walton, G. E., et al. (2012) “A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age.” British Journal of Nutrition, 107(10), 1466-1475.
  35. Toward, et al. (2012) “Effect of prebiotics on the human gut microbiota of elderly persons.” Gut microbes, 3(1), 57-60.
  36. Hopkins, Sharp, and Macfarlane. (2002) "Variation in human intestinal microbiota with age" Digestive and Liver Disease 34 S12-S18
  37. Thevaranjan, et al. (2017) "Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction" Cell Host & Microbe 21(4) 455-466.
  38. Yasui, H., et al. (1992)”Detection of Bifidobacterium strains that induce large quantities of IgA.” Microbial Ecology in Health and Disease 5(3) 155-162.
  39. Macfarlane, George T., and Sandra Macfarlane. (2002) “Diet and metabolism of the intestinal flora.” Bioscience and microflora 21(4) 199-208.
  40. Louis, et al. (2010) “Diversity of human colonic butyrate‐producing bacteria revealed by analysis of the butyryl‐CoA: acetate CoAtransferase gene.”Environmental microbiology 12(2) 304-314.
  41. Srinivasjois, Ravisha, Shripada Rao, and Sanjay Patole. (2013) “Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials.” Clinical nutrition 32(6) 958-965.
  42. Giovannini, and Group for the P.T.S. (2014) "Prebiotic Effect of an Infant Formula Supplemented with Galacto-Oligosaccharides: Randomized Multicenter Trial" Journal of the American College of Nutrition 33(5) 385-393.